Based on the Wall Street analyst consensus for 55 of CANC’s holdings.
CANC 12 Month Forecast
Average Price Target
$61.38▲(49.49% Upside)
Based on Wall Street analyst 12-month price targets for 55 of Tema Oncology ETF’s holdings in the last 3 months. The average price target is $61.38 with a high forecast of $76.48 and a low forecast of $44.98. The average price target represents a 49.49% change from the last price of $41.06.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$76.48
Average$61.38
Low$44.98
Past 12 Months12 Month Forecast$29$41$53$65$77Feb2026May2026Aug2026Nov2026Nov2027
What is CANC’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 55 of CANC’s holdings, Tema Oncology ETF’s 12-month average price target is $61.38.
What is CANC’s upside potential, based on the analysts’ average price target?
CANC’s average price target of $61.38 represents a 49.49% upside from its last price of $41.06.
Is CANC a Buy, Sell or Hold?
Tema Oncology ETF has a consensus rating of Strong Buy, based on the analyst consensus for 55 of CANC’s holdings: 52 rated Buy, 3 rated Hold and 0 rated Sell.
What is Tema Oncology ETF’s price target?
The average price target for Tema Oncology ETF is $61.38, based on Wall Street analyst 12-month price targets for 55 of CANC’s holdings, issued in the past 3 months. The highest price target is $76.48 and the lowest is $44.98. The average price target represents a 49.49% increase from the last price of $41.06.
What is CANC’s expense ratio?
CANC’s expense ratio is 0.75%.
How many holdings does CANC have?
CANC holds 57 assets.
How can I buy shares of CANC?
You can buy shares of CANC through a brokerage account. Compare brokers on our Best Online Brokers page.